The effect of COVID-19 vaccination on kidney function and HLA antibody formation in patients with end-stage kidney disease and on kidney replacement treatment

RECOVAC Consortium; Céline Imhof; A Lianne Messchendorp; Laura B Bungener; Bouke G Hepkema; Marcia M L Kho; Marlies E J Reinders; Frederike J Bemelman; Luuk B Hilbrands; Ron T Gansevoort; Jan Stephan F Sanders

doi:10.1093/ckj/sfae122

The effect of COVID-19 vaccination on kidney function and HLA antibody formation in patients with end-stage kidney disease and on kidney replacement treatment

RECOVAC Consortium, Céline Imhof^*, A Lianne Messchendorp, Laura B Bungener, Bouke G Hepkema, Marcia M L Kho, Marlies E J Reinders, Frederike J Bemelman, Luuk B Hilbrands, Ron T Gansevoort, Jan Stephan F Sanders

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

1 Citation (Scopus)

37 Downloads (Pure)

Original language	English
Article number	sfae122
Number of pages	3
Journal	Clinical Kidney Journal
Volume	17
Issue number	5
DOIs	https://doi.org/10.1093/ckj/sfae122
Publication status	Published - May-2024

Access to Document

10.1093/ckj/sfae122Licence: CC BY-NC

The effect of COVID-19 vaccination on kidney function and HLA antibody formation in patients with end-stage kidney disease and on kidney replacement treatment Final publisher's version, 290 KBLicence: CC BY-NC

Handle.net

Persistent link

Cite this

RECOVAC Consortium, Imhof, C., Messchendorp, A. L., Bungener, L. B., Hepkema, B. G., Kho, M. M. L., Reinders, M. E. J., Bemelman, F. J., Hilbrands, L. B., Gansevoort, R. T., & Sanders, J. S. F. (2024). The effect of COVID-19 vaccination on kidney function and HLA antibody formation in patients with end-stage kidney disease and on kidney replacement treatment. Clinical Kidney Journal, 17(5), Article sfae122. https://doi.org/10.1093/ckj/sfae122

@article{d720b98568d24339b18adf5868549851,

title = "The effect of COVID-19 vaccination on kidney function and HLA antibody formation in patients with end-stage kidney disease and on kidney replacement treatment",

author = "{RECOVAC Consortium} and C{\'e}line Imhof and Messchendorp, {A Lianne} and Bungener, {Laura B} and Hepkema, {Bouke G} and Kho, {Marcia M L} and Reinders, {Marlies E J} and Bemelman, {Frederike J} and Hilbrands, {Luuk B} and Gansevoort, {Ron T} and Sanders, {Jan Stephan F}",

year = "2024",

month = may,

doi = "10.1093/ckj/sfae122",

language = "English",

volume = "17",

journal = "Clinical Kidney Journal",

issn = "2048-8505",

publisher = "Oxford Univ. Press, New York",

number = "5",

}

RECOVAC Consortium, Imhof, C , Messchendorp, AL , Bungener, LB , Hepkema, BG, Kho, MML, Reinders, MEJ, Bemelman, FJ, Hilbrands, LB, Gansevoort, RT & Sanders, JSF 2024, 'The effect of COVID-19 vaccination on kidney function and HLA antibody formation in patients with end-stage kidney disease and on kidney replacement treatment', Clinical Kidney Journal, vol. 17, no. 5, sfae122. https://doi.org/10.1093/ckj/sfae122

The effect of COVID-19 vaccination on kidney function and HLA antibody formation in patients with end-stage kidney disease and on kidney replacement treatment. / RECOVAC Consortium ; Imhof, Céline ; Messchendorp, A Lianne et al.
In: Clinical Kidney Journal, Vol. 17, No. 5, sfae122, 05.2024.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - The effect of COVID-19 vaccination on kidney function and HLA antibody formation in patients with end-stage kidney disease and on kidney replacement treatment

AU - RECOVAC Consortium

AU - Imhof, Céline

AU - Messchendorp, A Lianne

AU - Bungener, Laura B

AU - Hepkema, Bouke G

AU - Kho, Marcia M L

AU - Reinders, Marlies E J

AU - Bemelman, Frederike J

AU - Hilbrands, Luuk B

AU - Gansevoort, Ron T

AU - Sanders, Jan Stephan F

PY - 2024/5

Y1 - 2024/5

U2 - 10.1093/ckj/sfae122

DO - 10.1093/ckj/sfae122

M3 - Article

C2 - 38770045

SN - 2048-8505

VL - 17

JO - Clinical Kidney Journal

JF - Clinical Kidney Journal

IS - 5

M1 - sfae122

ER -